K. Syrigos

1.2k total citations
18 papers, 294 citations indexed

About

K. Syrigos is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K. Syrigos has authored 18 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K. Syrigos's work include Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). K. Syrigos is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (3 papers) and Lung Cancer Treatments and Mutations (3 papers). K. Syrigos collaborates with scholars based in Greece, United States and Austria. K. Syrigos's co-authors include Muhammad Wasif Saif, Nektaria Makrilia, Giannis Mountzios, Evangelos Terpos, Muhammad Wasif Saif, Evangelos Dimakakos, Epaminontas Samantas, G. Klouvas, Thomas Makatsoris and Ioannis Xanthakis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

K. Syrigos

18 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Syrigos Greece 8 157 119 105 56 34 18 294
Xiaojun Tian China 12 219 1.4× 35 0.3× 90 0.9× 144 2.6× 35 1.0× 54 358
G Pastorino Italy 9 57 0.4× 162 1.4× 43 0.4× 47 0.8× 47 1.4× 21 267
Tomoyo Oguri Japan 11 173 1.1× 183 1.5× 34 0.3× 63 1.1× 39 1.1× 28 321
J P Bellocq France 9 85 0.5× 46 0.4× 139 1.3× 23 0.4× 74 2.2× 18 281
Satoshi Tamaru Japan 9 35 0.2× 59 0.5× 61 0.6× 34 0.6× 11 0.3× 46 255
Fabrizio Scognamillo Italy 10 51 0.3× 121 1.0× 106 1.0× 56 1.0× 56 1.6× 35 300
Sameh Daher Israel 10 155 1.0× 294 2.5× 40 0.4× 37 0.7× 21 0.6× 15 374
Danielle M. Pineda United States 8 139 0.9× 102 0.9× 135 1.3× 85 1.5× 47 1.4× 27 310
Marcus Langenskiöld Sweden 12 191 1.2× 91 0.8× 140 1.3× 73 1.3× 55 1.6× 24 358

Countries citing papers authored by K. Syrigos

Since Specialization
Citations

This map shows the geographic impact of K. Syrigos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Syrigos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Syrigos more than expected).

Fields of papers citing papers by K. Syrigos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Syrigos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Syrigos. The network helps show where K. Syrigos may publish in the future.

Co-authorship network of co-authors of K. Syrigos

This figure shows the co-authorship network connecting the top 25 collaborators of K. Syrigos. A scholar is included among the top collaborators of K. Syrigos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Syrigos. K. Syrigos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Grapsa, Dimitra, et al.. (2021). P38.13 Cytology-Histology Concordance for Diagnosis, Histological Subtyping and Molecular Profiling of Lung Cancer. Journal of Thoracic Oncology. 16(3). S463–S463. 2 indexed citations
2.
Reck, Martin, K. Syrigos, Skaidrius Miliauskas, et al.. (2019). Nintedanib (N) + docetaxel (D) after immunotherapy in adenocarcinoma non-small cell lung cancer (NSCLC): First results from the non-interventional LUME-BioNIS study. Annals of Oncology. 30. xi28–xi29. 2 indexed citations
3.
Gerotziafas, Grigoris, Alex C. Spyropoulos, K. Syrigos, et al.. (2018). First External Validation of the New COMPASS-CAT Risk Assessment Model for Ambulatory Patients with Breast, Colorectal, Lung or Ovarian Cancer. Thrombosis Research. 164. S232–S232. 1 indexed citations
4.
Legakis, Ioannis, Muhammad Wasif Saif, & K. Syrigos. (2017). Therapeutic Challenges in Neuroendocrine Tumors. Anti-Cancer Agents in Medicinal Chemistry. 17(7). 902–919. 3 indexed citations
5.
Soura, Efthymia, et al.. (2016). Can hair re‐growth be considered an early clinical marker of treatment resistance to Hedgehog inhibitors in patients with advanced basal cell carcinoma? A report of two cases. Journal of the European Academy of Dermatology and Venereology. 30(10). 1726–1729. 10 indexed citations
6.
Syrigos, K., et al.. (2015). Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection. World Allergy Organization Journal. 8(6). A22–A22. 21 indexed citations
7.
Toki, Maria, Muhammad Wasif Saif, & K. Syrigos. (2014). Hypersensitivity reactions associated with oxaliplatin and their clinical management. Expert Opinion on Drug Safety. 13(11). 1545–1554. 11 indexed citations
8.
Briasoulis, Evangelos, Gerasimos Aravantinos, George Kouvatseas, et al.. (2013). Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study. BMC Cancer. 13(1). 263–263. 63 indexed citations
9.
Dimakakos, Evangelos, et al.. (2012). Prevalence, risk and aggravating factors of chronic venous disease: an epidemiological survey of the general population of Greece. Phlebology The Journal of Venous Disease. 28(4). 184–190. 14 indexed citations
10.
Saif, Muhammad Wasif, Barbara G. Fallon, & K. Syrigos. (2012). Is There a Role of Targeted Agents in the Management of Adrenocortical Cancers?. SHILAP Revista de lepidopterología. 2012. 1–5. 1 indexed citations
11.
Kaley, Kristin, et al.. (2012). Anaphylactic reaction associated with intravenous administration of folinic acid in a patient with colon cancer.. PubMed. 25(6). 995–6. 4 indexed citations
12.
Mountzios, Giannis, et al.. (2011). Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data. Clinical Lung Cancer. 12(6). 341–349. 24 indexed citations
13.
Saif, Muhammad Wasif, et al.. (2010). Gastric cancer in the elderly: An overview. European Journal of Surgical Oncology. 36(8). 709–717. 109 indexed citations
14.
Legakis, Ioannis & K. Syrigos. (2010). Obesity Modulation - The Role in Carcinogenesis. Anti-Cancer Agents in Medicinal Chemistry. 10(6). 481–490. 6 indexed citations
15.
Anagnostou, Valsamo, Taxiarchis Botsis, Vassiliki Zolota, et al.. (2010). Molecular classification of non-small cell lung cancer using a four protein quantitative assay.. Journal of Clinical Oncology. 28(15_suppl). 10528–10528. 1 indexed citations
16.
Dimou, Anastasios, K. Syrigos, Surendra Kumar Agarwal, et al.. (2010). Frequency of L858R and D746-750 EGFR mutations in 411 Caucasian patients with non-small cell lung cancer measured by mutation-specific antibodies.. Journal of Clinical Oncology. 28(15_suppl). 1587–1587. 1 indexed citations
17.
Mountzios, Giannis, Meletios Α. Dimopoulos, A. Bamias, et al.. (2009). 1086 Biochemical markers of bone remodeling as predictors of skeletal morbidity and outcome in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid. European Journal of Cancer Supplements. 7(2). 110–111. 2 indexed citations
18.
Karayiannakis, Anastasios J., K. Syrigos, Antria Savva, et al.. (2002). Serum E-cadherin concentrations and their response during laparoscopic and open cholecystectomy. Surgical Endoscopy. 16(11). 1551–1554. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojun Tian Breakdown of academic impact, for papers by G Pastorino Breakdown of academic impact, for papers by Tomoyo Oguri Breakdown of academic impact, for papers by J P Bellocq Breakdown of academic impact, for papers by Satoshi Tamaru Breakdown of academic impact, for papers by Fabrizio Scognamillo Breakdown of academic impact, for papers by Sameh Daher Breakdown of academic impact, for papers by Danielle M. Pineda Breakdown of academic impact, for papers by Marcus Langenskiöld
Rankless by CCL
2026